 Donor seropositivity prednisolone therapy risk factors cytomegalovirus infection disease cyclosporin-treated renal allograft recipients importance blood transfusion donor seropositivity therapy risk factors cytomegalovirus infection cyclosporin-treated renal allograft recipients Primary infection patients cent recurrent infection patients cent Receipt blood unselected donors transplantation incidence primary infection transfused patients Kidney donor seropositivity maintenance prednisolone addition increases incidence primary recurrent infection Cytomegalovirus infection mild bacterial pneumonias patients recurrent cytomegalovirus infection absence severe cytomegalovirus disease minimal use prednisolone Matching seronegative donors seronegative recipients unjustifiable cyclosporin-treated renal transplant patients